Skip to content
BidBenchmark

Contract award

EXELAN PHARMACEUTICALS INC

EMERGENCY PHARMACY LENALIDOMIDE FOR PATIENT TREATMENT
PIID
36C25926F0100
Award key
CONT_AWD_36C25926F0100_3600_36F79720D0227_3600
Recipient UEI
FYZXNHSQTMG8
Parent award
CONT_IDV_36F79720D0227_3600
Source as of
Current award value
$587,0073
Obligated to date
$587,0072
Potential with options
$587,0073
Awarding agency
Department of Veterans AffairsDepartment of Veterans Affairs
Place of performance
Boca Raton, Florida
Set-aside
None
Pricing
Firm Fixed Price
Competition
Full and Open Competition1 offers received
Period of performance
Feb 5, 2026Feb 8, 2026Through Feb 8, 2026 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Feb 5, 2026Initial award$587,007.48$587,007.40
P00001Feb 5, 2026M$0.00$587,007.40
P00002Aug 14, 2026C-$0.08$587,007.40

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 17, 2026usaspending_contract_csv@2026.08.2b6807e21e118
contractor_idUSAspending.govAug 17, 2026usaspending_contract_csv@2026.08.2b6807e21e118
current_award_valueUSAspending.govAug 17, 2026usaspending_contract_csv@2026.08.2b6807e21e118
naics_codeUSAspending.govAug 17, 2026usaspending_contract_csv@2026.08.2b6807e21e118
potential_award_valueUSAspending.govAug 17, 2026usaspending_contract_csv@2026.08.2b6807e21e118
psc_codeUSAspending.govAug 17, 2026usaspending_contract_csv@2026.08.2b6807e21e118
total_obligatedUSAspending.govAug 17, 2026usaspending_contract_csv@2026.08.2b6807e21e118

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 3 transaction records parsed from USAspending.gov, retrieved Aug 17, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
36C25926F0100 — EXELAN PHARMACEUTICALS INC · BidBenchmark